Page last updated: 2024-11-06

hydrocortisone acetate and Meningeal Neoplasms

hydrocortisone acetate has been researched along with Meningeal Neoplasms in 1 studies

hydrocortisone acetate: RN given refers to cpd without isomeric designation

Meningeal Neoplasms: Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.

Research Excerpts

ExcerptRelevanceReference
"This retrospective study evaluates the results of a regimen of high-dose intrathecal methotrexate and the prognostic factors for the response in patients with meningeal from breast carcinoma."9.08Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen. ( Asselain, B; Beuzeboc, P; Dieras, V; Dorval, T; Fizazi, K; Jouve, M; Palangie, T; Pouillart, P; Vincent-Salomon, A, 1996)
"This retrospective study evaluates the results of a regimen of high-dose intrathecal methotrexate and the prognostic factors for the response in patients with meningeal from breast carcinoma."5.08Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen. ( Asselain, B; Beuzeboc, P; Dieras, V; Dorval, T; Fizazi, K; Jouve, M; Palangie, T; Pouillart, P; Vincent-Salomon, A, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fizazi, K1
Asselain, B1
Vincent-Salomon, A1
Jouve, M1
Dieras, V1
Palangie, T1
Beuzeboc, P1
Dorval, T1
Pouillart, P1

Trials

1 trial available for hydrocortisone acetate and Meningeal Neoplasms

ArticleYear
Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
    Cancer, 1996, Apr-01, Volume: 77, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Dose-Respo

1996